Coverage by line
Premium dollars by benefit type (bundled lines overlap)
- Health$4.0M
- Prescription drug$4.0M
- Life$206K
- Short-term disability$206K
- Long-term disability$206K
- Other$206K
- +2 more
Sponsor portfolio
THERAVANCE BIOPHARMA U.S., LLC
EIN 46-3451245biotechnologyLatest filing 2025
Plans
2
Retirement
1
$94.4M assets
Welfare
1
$4.4M premiums
Participants
415
901 GATEWAY BLVD - SOUTH SAN FRANCISCO, CA 94080650-808-6000theravance.comLinkedIn51-200 employeesbiotechnology
Plans on this EIN
2 filingsBenefits portfolio analytics
1 plan / $4.4M premiums / 193 covered livesCarrier market share
Premium dollars by Schedule A carrier
88%top
- AETNA LIFE INSURANCE COMPANY88%
- SUN LIFE ASSURANCE COMPANY OF CANADA9%
- KAISER FOUNDATION HEALTH PLAN INC3%
Broker market share
Schedule A broker compensation
100%top
- MARSH & MCLENNAN AGENCY LLC100%
Plan deep-dives
Per-plan teasers. The full analytics (fees vs peers, audit grade, trajectory, counterparties) live on each plan detail page.Retirement#001
THERAVANCE BIOPHARMA U.S., LLC 401(K) PLAN
401k
Assets$94.4M
Participants328
Inside the deep dive
Fees vs peersAudit gradeAsset trajectoryContributionsSch C providers
Open plan deep dive
Welfare#503
THERAVANCE BIOPHARMA US LLC HEALTH AND WELFARE PLAN
Fully Insured - AETNA LIFE INSURANCE COMPANY
Premiums$4.4M
Covered lives193
Inside the deep dive
Premium breakdownCarriersBrokersCoverage stats
Open plan deep dive
Retirement plans1
| Plan # | Name | Type | Assets | Participants | Latest year | |
|---|---|---|---|---|---|---|
| 001 | THERAVANCE BIOPHARMA U.S., LLC 401(K) PLAN | 401k | $94.4M | 328 | 2025 |
Welfare plans1
| Plan # | Name | Funding | Carrier | Premiums | Covered | Latest year | |
|---|---|---|---|---|---|---|---|
| 503 | THERAVANCE BIOPHARMA US LLC HEALTH AND WELFARE PLAN | Fully Insured | AETNA LIFE INSURANCE COMPANY | $4.4M | 193 | 2025 |
Retirement plans
Welfare plans